Stay updated on Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.

Latest updates to the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page
- ChecktodayChange DetectedThe footer revision changes from v3.7.2 to v3.8.0 on the 403 Forbidden page.SummaryDifference0.2%

- Check7 days agoChange DetectedA banner announces that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a terminology transition and links to updates and FAQs.SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check21 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, effectively blocking access to the record. A minimal header with a Home link and a revision tag (Revision: v3.7.0) is shown.SummaryDifference16%

- Check63 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a new version of the page. This appears to be a minor update to the page rather than a change to study details or results.SummaryDifference0.0%

Stay in the know with updates to Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.